international nonproprietary name dronabinol also known trade names marinol syndros reduvo adversa generic name molecule pharmaceutical context indications appetite stimulant antiemetic sleep apnea approved fda safe effective hivaidsinduced anorexia chemotherapyinduced nausea vomiting dronabinol principal psychoactive constituent enantiomer form found dronabinol include tetrahydrocannabinol thc isomers cannabidiol dronabinol used stimulate appetite therefore weight gain patients hivaids cancer also used treat chemotherapyinduced nausea dronabinol demonstrated analgesic efficacy majority studies chronic pain data acute pain less dronabinol may useful treating cannabis addiction shown reduce cannabis withdrawal symptoms subjective effects dronabinol demonstrates significant improvement sleep apnea phase clinical trials completed fda approval mild overdose dronabinol presents drowsiness drymouth euphoria tachycardia whereas severe overdose presents lethargy slurred speech decreased motor coordination postural dronabinol initially approved united states food drug administration may may drug enforcement administration dea issued final rule statement policy authorizing rescheduling synthetic dronabinol sesame oil encapsulated soft gelatin capsules schedule schedule ii dea fr permitted medical use marinol albeit severe restrictions associated schedule ii instance refills marinol prescriptions permitted april commission narcotic drugs accordance article paragraphs convention psychotropic substances decided also referred stereochemical variants transferred schedule schedule ii convention released many restrictions imposed convention facilitating marketing article published issue journal psychoactive drugs found healthcare professionals detected indication scriptchasing doctorshopping among patients prescribed dronabinol authors state marinol low potential source needed united states marinol rescheduled schedule ii iii controlled substances act reflecting finding thc potential abuse less cocaine rescheduling constituted part argument petition removal cannabis schedule controlled substances act petitioner jon gettman noted cannabis natural source dronabinol thc ingredient marinol schedule iii drug grounds schedule cannabis restrictive schedule source needed world health organization expert committee drug dependence recommended transferring thc schedule iv convention citing medical uses low abuse committee recommended transferring schedule single convention narcotic drugs recommendations rejected united nations commission narcotic dronabinol marketed marinol registered trademark solvay pharmaceuticals dronabinol also marketed sold distributed par pharmaceutical companies terms license distribution agreement svc pharma lp affiliate rhodes technologies marinol insys pharmaceuticals syndroscitation needed dronabinol available prescription drug marinol syndros several countries including united states germany south africa canada tetra biopharma filed new drug submission nds health canada dronabinol soft gel capsules marketed tetra two dronabinol drugs new routes administration limit firstpass metabolism inhaled thcbased dronabinol drug mucoadhesivedelivery dronabinol drug accelerated new drug application nda pathway us canadian united states marinol schedule iii drug available prescription considered nonnarcotic low risk physical mental dependence efforts get cannabis rescheduled analogous marinol succeeded thus far though petition accepted dea result rescheduling marinol schedule ii schedule iii refills permitted substance marinols us food drug administration fda approval medical use raised much cannabis still illegal federal female cannabis plants contain dronabinol least including cannabidiol cbd thought major anticonvulsant helps people multiple cannabichromene cbc antiinflammatory may contribute painkilling effect takes one hour marinol reach full systemic compared seconds minutes smoked vaporized mark kleiman director drug policy analysis program uclas school public affairs said marinol wasnt fun made user feel bad could approved without fear would penetrate recreational market used club beat back advocates whole cannabis clinical trials comparing use cannabis extracts marinol treatment cancer cachexia demonstrated equal efficacy wellbeing among subjects two treatment united states federal law currently registers dronabinol schedule iii controlled substance cannabinoids remain schedule except synthetics like nabilone httpsenwikipediaorgwikidronabinol